# FDA 483 - Abbott Laboratories - November 01, 2022

Source: https://www.keypedia.com/records/483/abbott-laboratories/5d04375e-2ec6-4659-96b5-06588e37a6a7

> FDA 483 for Abbott Laboratories on November 01, 2022. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Abbott Laboratories
- Inspection Date: 2022-11-01
- Product Type: other
- Office Name: Cincinnati District Office
- Summary: An FDA inspection of Abbott Nutrition, Division of Abbott Laboratories in Columbus, OH, from October 19 to November 1, 2022, identified a critical issue with system maintenance. Specifically, a repaired capper component led to a reject system malfunction, failing to remove defective products from the line. This deficiency resulted in a voluntary recall of several 2oz Similac and Pedialyte products.

## Related Documents

- [483 - 2009-04-01](https://www.keypedia.com/records/483/abbott-laboratories/3c5b7ee8-86d1-4808-a50c-8fdab0b1e77b)

## Related Officers

- [Craig P. Seaborn](https://www.keypedia.com/people/craig-p-seaborn/730fc254-fcc3-42a0-803d-0c0cb1436b82)

Company: https://www.keypedia.com/companies/abbott-laboratories/ac21c076-0bd2-4d3f-87fc-a26601f559d4

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22